The HECTD3 E3 ubiquitin ligase suppresses cisplatin-induced apoptosis via stabilizing MALT1

Neoplasia (United States)

Volumn 15, Issue 1, 2013, Pages 39-48

  Li, Yi ^a,b   Chen, Xi ^a,c   Wang, Zehua ^a   Zhao, Dong ^d   Chen, Hui ^e   Chen, Wenlin ^f   Zhou, Zhongmei ^a   Zhang, Junran ^g   Zhang, Jing ^e   Li, Hongmin ^e,h   Chen, Ceshi ^a  

^a KUNMING INSTITUTE OF ZOOLOGY   (China)

^b CANCER HOSPITAL   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^d ALBANY MEDICAL COLLEGE   (United States)

^e WADSWORTH CENTER   (United States)

^f KUNMING MEDICAL UNIVERSITY   (China)

^g CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 7; CASPASE 8; CISPLATIN; GLUTATHIONE TRANSFERASE; HOMOLOGOUS TO THE E6 ASSOCIATED PROTEIN CARBOXYL TERMINUS DOMAIN CONTAINING 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MUCOSA ASSOCIATED LYMPHOID TISSUE 1 PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BINDING AFFINITY; BREAST CANCER; CANCER CELL; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN STABILITY; SCID MOUSE; TUMOR VOLUME; TWO HYBRID SYSTEM; UBIQUITINATION; WESTERN BLOTTING;

EID: 84873051209     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.121362     Document Type: Article

References (17)

1. Chen C, Seth AK, and Aplin AE (2006). Genetic and expression aberrations of e3 ubiquitin ligases in human breast cancer. Mol Cancer Res 4, 695-707.
2. Woelk T, Sigismund S, Penengo L, and Polo S (2007). The ubiquitination code: a signalling problem. Cell Div 2, 11.
3. Pal M, Varga K, Nagy O, and Deak P (2007). Characterization of the Apc10/Doc1 subunit of the anaphase promoting complex in Drosophila melanogaster. Acta Biol Hung 58(suppl), 51-64.
4. Kaustov L, Lukin J, Lemak A, Duan S, Ho M, Doherty R, Penn LZ, and Arrowsmith CH (2007). The conserved CPH domains of Cul7 and PARC are protein-protein interaction modules that bind the tetramerization domain of p53. J Biol Chem 282, 11300-11307.
5. Yu J, Lan J, Zhu Y, Li X, Lai X, Xue Y, Jin C, and Huang H (2008). The E3 ubiquitin ligase HECTD3 regulates ubiquitination and degradation of Tara. Biochem Biophys Res Commun 367, 805-812.
6. Zhang L, Kang L, Bond W, and Zhang N (2009). Interaction between syntaxin 8 and HECTd3, a HECT domain ligase. Cell Mol Neurobiol 29, 115-121.
7. Oeckinghaus A, Wegener E, Welteke V, Ferch U, Arslan SC, Ruland J, Scheidereit C, and Krappmann D (2007). Malt1 ubiquitination triggers NF-κB signaling upon T-cell activation. EMBO J 26, 4634-4645.
8. Coornaert B, Baens M, Heyninck K, Bekaert T, Haegman M, Staal J, Sun L, Chen ZJ, Marynen P, and Beyaert R (2008). T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-κB inhibitor A20. Nat Immunol 9, 263-271.
9. Hailfinger S, Nogai H, Pelzer C, Jaworski M, Cabalzar K, Charton JE, Guzzardi M, Decaillet C, Grau M, Dorken B, et al. (2011). Malt1-dependent RelB cleavage promotes canonical NF-κB activation in lymphocytes and lymphoma cell lines. Proc Natl Acad Sci USA 108, 14596-14601.
10. Staal J, Driege Y, Bekaert T, Demeyer A, Muyllaert D, Van Damme P, Gevaert K, and Beyaert R (2011). T-cell receptor-induced JNK activation requires proteolytic inactivation of CYLD by MALT1. EMBO J 30, 1742-1752.
11. Kawadler H, Gantz MA, Riley JL, and Yang X (2008). The paracaspase MALT1 controls caspase-8 activation during lymphocyte proliferation. Mol Cell 31, 415-421.
12. Li Y, Zhou Z, and Chen C (2008). WWdomain-containing E3 ubiquitin protein ligase 1 targets p63 transcription factor for ubiquitin-mediated proteasomal degradation and regulates apoptosis. Cell Death Differ 15, 1941-1951.
13. Qiu L and Dhe-Paganon S (2011). Oligomeric structure of the MALT1 tandem Ig-like domains. PLoS One 6, e23220.
14. Li H, Zhou Y, Guo Y, Li Z, Eisele L, and Mourad W (2007). Zinc induces dimerization of the class II major histocompatibility complex molecule that leads to cooperative binding to a superantigen. J Biol Chem 282, 5991-6000.
15. Chen C, Zhou Z, Ross JS, Zhou W, and Dong JT (2007). The amplified WWP1 gene is a potential molecular target in breast cancer. Int J Cancer 121, 2834-2841.
16. Hosokawa Y (2005). Anti-apoptotic action of API2-MALT1 fusion protein involved in t(11;18)(q21;q21) MALT lymphoma. Apoptosis 10, 25-34.
17. Blanc C, Deveraux QL, Krajewski S, Janicke RU, Porter AG, Reed JC, Jaggi R, and Marti A (2000). Caspase-3 is essential for procaspase-9 processing and cisplatin-induced apoptosis of MCF-7 breast cancer cells. Cancer Res 60, 4386-4390.